CL2011003271A1 - Polipeptido l1 del virus de papiloma humano (hpv) tipo 18 que comprende cuando menos un peptido que comprende un epitopo de un polipeptido l2; capsomero; particula parecida a virus (vlp); composicion inmunogenica; molecula de acido nucleico; polipeptido; metodo para producir polipeptido; metodo para producir composicion inmunogenica. - Google Patents
Polipeptido l1 del virus de papiloma humano (hpv) tipo 18 que comprende cuando menos un peptido que comprende un epitopo de un polipeptido l2; capsomero; particula parecida a virus (vlp); composicion inmunogenica; molecula de acido nucleico; polipeptido; metodo para producir polipeptido; metodo para producir composicion inmunogenica.Info
- Publication number
- CL2011003271A1 CL2011003271A1 CL2011003271A CL2011003271A CL2011003271A1 CL 2011003271 A1 CL2011003271 A1 CL 2011003271A1 CL 2011003271 A CL2011003271 A CL 2011003271A CL 2011003271 A CL2011003271 A CL 2011003271A CL 2011003271 A1 CL2011003271 A1 CL 2011003271A1
- Authority
- CL
- Chile
- Prior art keywords
- polypeptide
- producing
- immunogenic composition
- capsomer
- vlp
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/01—DNA viruses
- C07K14/025—Papovaviridae, e.g. papillomavirus, polyomavirus, SV40, BK virus, JC virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5258—Virus-like particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20023—Virus like particles [VLP]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Polipéptido L1 del virus de papiloma humano (HPV) tipo 18 que comprende cuando menos un péptido que comprende un epítopo de un polipéptido L2; capsómero; partícula parecida a virus (VLP); composición inmunogénica; molécula de ácido nucleico; polipéptido; método para producir polipéptido; método para producir composición inmunogénica.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US22035809P | 2009-06-25 | 2009-06-25 | |
US23988009P | 2009-09-04 | 2009-09-04 | |
US32210210P | 2010-04-08 | 2010-04-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2011003271A1 true CL2011003271A1 (es) | 2012-08-31 |
Family
ID=43014491
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2011003271A CL2011003271A1 (es) | 2009-06-25 | 2011-12-22 | Polipeptido l1 del virus de papiloma humano (hpv) tipo 18 que comprende cuando menos un peptido que comprende un epitopo de un polipeptido l2; capsomero; particula parecida a virus (vlp); composicion inmunogenica; molecula de acido nucleico; polipeptido; metodo para producir polipeptido; metodo para producir composicion inmunogenica. |
Country Status (20)
Country | Link |
---|---|
US (1) | US20120087937A1 (es) |
EP (1) | EP2445525A2 (es) |
JP (1) | JP2012530505A (es) |
KR (1) | KR20120098580A (es) |
CN (1) | CN102497880A (es) |
AU (1) | AU2010264695A1 (es) |
BR (1) | BRPI1014718A2 (es) |
CA (1) | CA2768172A1 (es) |
CL (1) | CL2011003271A1 (es) |
CO (1) | CO6480995A2 (es) |
CR (1) | CR20120026A (es) |
DO (1) | DOP2011000396A (es) |
EA (1) | EA022213B1 (es) |
IL (1) | IL217094A0 (es) |
MA (1) | MA33440B1 (es) |
MX (1) | MX2011013744A (es) |
PE (1) | PE20120563A1 (es) |
SG (1) | SG177269A1 (es) |
WO (1) | WO2010149752A2 (es) |
ZA (1) | ZA201109453B (es) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2653251T3 (es) * | 2009-04-10 | 2018-02-06 | The Johns Hopkins University | Partículas de tipo papilomavirus (VLP) como vacunas de amplio espectro del virus del papiloma humano (VPH) |
EP2785842A4 (en) * | 2011-12-01 | 2015-11-25 | Univ Cape Town | HPV CHIMERE PARTICLE |
JP2015514696A (ja) | 2012-03-18 | 2015-05-21 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | ヒト・パピローマウイルスに対するワクチン接種方法 |
CN103864936B (zh) * | 2012-12-11 | 2018-01-23 | 中国疾病预防控制中心病毒病预防控制所 | Hpv18型l2ne7e6融合蛋白基因、表达载体、方法、菌株和用途 |
EP2940133A4 (en) * | 2012-12-25 | 2016-07-06 | Chemo Sero Therapeut Res Inst | VACCINE AGAINST HPV AND / OR HEPATITIS B INFECTION CONTAINING CHIMERIC HPV / HBS PROTEIN AS AN ACTIVE INGREDIENT |
CN117187262A (zh) * | 2014-02-18 | 2023-12-08 | 上海泽润生物科技有限公司 | 重组人乳头瘤病毒蛋白表达 |
CN104531741B (zh) * | 2014-08-22 | 2016-08-24 | 天津康希诺生物技术有限公司 | 增强hpv抗原表位肽免疫原性的方法及类病毒颗粒、颗粒制备方法与应用 |
US10238729B2 (en) | 2014-10-24 | 2019-03-26 | Hpvvax, Llc | Cancer and skin lesion treatment |
US10799574B2 (en) | 2014-10-24 | 2020-10-13 | Hpvvax. Llc | Method and composition for treating cancer or skin lesion using a vaccine |
US11129882B2 (en) | 2015-10-30 | 2021-09-28 | University Of Copenhagen | Virus like particle with efficient epitope display |
WO2017092710A1 (zh) * | 2015-12-04 | 2017-06-08 | 厦门大学 | 一种人乳头瘤病毒58型l1蛋白的突变体 |
JP2019506435A (ja) * | 2016-02-27 | 2019-03-07 | エイチピーブイヴァックス, リミテッド ライアビリティー カンパニー.Hpvvax, Llc. | ワクチンを使用して癌または皮膚病変を治療するための方法および組成物 |
CN107188967B (zh) * | 2016-03-15 | 2020-03-31 | 中国医学科学院基础医学研究所 | 一种乳头瘤病毒嵌合蛋白及其用途 |
CN107188966B (zh) * | 2016-03-15 | 2020-03-31 | 中国医学科学院基础医学研究所 | 一种乳头瘤病毒嵌合蛋白及其用途 |
CN109251235B (zh) * | 2017-07-14 | 2021-04-27 | 厦门大学 | 一种人乳头瘤病毒16型l1蛋白的突变体 |
CN110950935A (zh) * | 2018-09-26 | 2020-04-03 | 厦门大学 | 一种人乳头瘤病毒51型l1蛋白的突变体 |
CN114127097A (zh) * | 2019-07-19 | 2022-03-01 | 神州细胞工程有限公司 | 嵌合的人乳头瘤病毒56型l1蛋白 |
WO2021013067A1 (zh) * | 2019-07-19 | 2021-01-28 | 神州细胞工程有限公司 | 嵌合的人乳头瘤病毒6型l1蛋白 |
WO2021013077A1 (zh) * | 2019-07-19 | 2021-01-28 | 神州细胞工程有限公司 | 嵌合的人乳头瘤病毒58型l1蛋白 |
CN111944834A (zh) * | 2020-09-04 | 2020-11-17 | 吉林医药学院 | 人乳头瘤病毒16型表位嵌合l1的重组载体、重组蛋白、病毒样颗粒及其制备和应用 |
CN112300290B (zh) * | 2020-09-30 | 2022-04-01 | 北京康乐卫士生物技术股份有限公司 | 一种使用乳头瘤病毒类病毒颗粒递呈抗原的新型冠状病毒多肽疫苗 |
CN114716562B (zh) * | 2021-01-04 | 2023-11-10 | 中国医学科学院基础医学研究所 | 一种人乳头瘤病毒58型嵌合蛋白及其用途 |
CN114716561B (zh) * | 2021-01-04 | 2024-03-12 | 中国医学科学院基础医学研究所 | 一种人乳头瘤病毒31型嵌合蛋白及其用途 |
CN114716560B (zh) * | 2021-01-04 | 2024-02-02 | 中国医学科学院基础医学研究所 | 一种人乳头瘤病毒18型嵌合蛋白及其用途 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL117459A (en) * | 1995-03-22 | 2005-11-20 | Merck & Co Inc | Dna encoding human papillomavirus type 18 |
US7351533B2 (en) | 1997-09-05 | 2008-04-01 | Medimmune, Inc. | In vitro method for disassmbly/reassembly of papillomavirus virus-like particles (VLPs). Homogeneous VLP and cavsomere compositions produced by said methods: use thereof as vehicle for improved purification, and delivery of active agents |
DK1015561T3 (da) | 1997-09-05 | 2006-11-13 | Medimmune Inc | In vitro-fremgangsmåde til adskillelse/gensamling af papillomavirus-lignende partikler (VLP'er) |
PT1012348E (pt) | 1997-09-16 | 2002-11-29 | Innogenetics Nv | Deteccao do virus do papiloma humano por pcr e hibridacao reversa tipo-especifica |
PT1126876E (pt) | 1998-10-16 | 2007-04-30 | Glaxosmithkline Biolog Sa | Sistemas adjuvantes e vacinas |
GB9921146D0 (en) * | 1999-09-07 | 1999-11-10 | Smithkline Beecham Biolog | Novel composition |
JP2004538010A (ja) | 2001-08-08 | 2004-12-24 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | アッセイ |
GB0206360D0 (en) | 2002-03-18 | 2002-05-01 | Glaxosmithkline Biolog Sa | Viral antigens |
PT1506222E (pt) * | 2002-05-17 | 2009-06-12 | Univ Cape Town | Proteínas l1 quiméricas do papilomavírus humano 16 incluindo um péptido l2, partículas semelhantes a vírus preparadas a partir daquelas e um método de preparação das partículas |
GB0228715D0 (en) | 2002-12-09 | 2003-01-15 | Glaxosmithkline Biolog Sa | Vaccine |
CN101193653B (zh) | 2005-02-01 | 2013-03-27 | 美国政府健康及人类服务部 | 用于诱导广泛交叉中和抗体的乳头瘤病毒l2 n末端肽 |
JP4825958B2 (ja) * | 2005-08-10 | 2011-11-30 | 財団法人ヒューマンサイエンス振興財団 | 高リスク群ヒトパピローマウイルスの中和抗体を誘導する抗原 |
MX2009014246A (es) | 2007-06-26 | 2010-03-31 | Japan Health Science Found | Antigeno de vacuna con la capacidad de inducir anticuerpo de neutralizacion y reaccion cruzada contra virus de papiloma humano del tipo de alto riesgo. |
AP2010005284A0 (en) * | 2007-11-02 | 2010-06-30 | Univ Johns Hopkins | Multitype HPV peptide compositions and methods fortreatment or prevention of human papillomavirus i nfection |
AU2009275909A1 (en) | 2008-07-31 | 2010-02-04 | Glaxosmithkline Biologicals S.A. | Vaccine against HPV |
-
2010
- 2010-06-24 SG SG2011093572A patent/SG177269A1/en unknown
- 2010-06-24 CA CA2768172A patent/CA2768172A1/en not_active Abandoned
- 2010-06-24 PE PE2011002154A patent/PE20120563A1/es not_active Application Discontinuation
- 2010-06-24 WO PCT/EP2010/059024 patent/WO2010149752A2/en active Application Filing
- 2010-06-24 BR BRPI1014718A patent/BRPI1014718A2/pt not_active IP Right Cessation
- 2010-06-24 JP JP2012516750A patent/JP2012530505A/ja active Pending
- 2010-06-24 US US13/378,446 patent/US20120087937A1/en not_active Abandoned
- 2010-06-24 EA EA201190327A patent/EA022213B1/ru not_active IP Right Cessation
- 2010-06-24 MX MX2011013744A patent/MX2011013744A/es not_active Application Discontinuation
- 2010-06-24 KR KR1020127001919A patent/KR20120098580A/ko not_active Application Discontinuation
- 2010-06-24 AU AU2010264695A patent/AU2010264695A1/en not_active Abandoned
- 2010-06-24 CN CN2010800386242A patent/CN102497880A/zh active Pending
- 2010-06-24 EP EP10727731A patent/EP2445525A2/en not_active Withdrawn
- 2010-06-24 MA MA34546A patent/MA33440B1/fr unknown
-
2011
- 2011-12-19 DO DO2011000396A patent/DOP2011000396A/es unknown
- 2011-12-20 IL IL217094A patent/IL217094A0/en unknown
- 2011-12-21 ZA ZA2011/09453A patent/ZA201109453B/en unknown
- 2011-12-22 CL CL2011003271A patent/CL2011003271A1/es unknown
-
2012
- 2012-01-04 CO CO12001297A patent/CO6480995A2/es unknown
- 2012-01-16 CR CR20120026A patent/CR20120026A/es unknown
Also Published As
Publication number | Publication date |
---|---|
DOP2011000396A (es) | 2012-02-15 |
PE20120563A1 (es) | 2012-05-17 |
WO2010149752A3 (en) | 2011-03-31 |
CR20120026A (es) | 2012-04-13 |
BRPI1014718A2 (pt) | 2016-04-12 |
US20120087937A1 (en) | 2012-04-12 |
KR20120098580A (ko) | 2012-09-05 |
CN102497880A (zh) | 2012-06-13 |
CO6480995A2 (es) | 2012-07-16 |
ZA201109453B (en) | 2012-08-29 |
CA2768172A1 (en) | 2010-12-29 |
SG177269A1 (en) | 2012-02-28 |
MA33440B1 (fr) | 2012-07-03 |
IL217094A0 (en) | 2012-02-29 |
MX2011013744A (es) | 2012-09-28 |
EA201190327A1 (ru) | 2012-07-30 |
WO2010149752A2 (en) | 2010-12-29 |
JP2012530505A (ja) | 2012-12-06 |
EP2445525A2 (en) | 2012-05-02 |
EA022213B1 (ru) | 2015-11-30 |
AU2010264695A1 (en) | 2012-01-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2011003271A1 (es) | Polipeptido l1 del virus de papiloma humano (hpv) tipo 18 que comprende cuando menos un peptido que comprende un epitopo de un polipeptido l2; capsomero; particula parecida a virus (vlp); composicion inmunogenica; molecula de acido nucleico; polipeptido; metodo para producir polipeptido; metodo para producir composicion inmunogenica. | |
MY161965A (en) | New influenza virus immunizing epitope | |
TN2009000557A1 (en) | Influenza virus-like particles (vlps) comprising hemagglutinin produced within a plant | |
BRPI1015053A2 (pt) | partículas similares a vírus da influenza quiméricas compreendendo hemaglutinina | |
TR201908199T4 (tr) | HPV'ye karşı aşılar. | |
WO2011034953A3 (en) | Lassa virus-like particles and methods of production thereof | |
WO2010003225A8 (en) | Influenza virus-like particles (vlps) comprising hemagglutinin | |
WO2010118424A3 (en) | Papillomavirus-like particles (vlp) as broad spectrum human papillomavirus (hpv) vaccines | |
NZ730802A (en) | Therapeutic hpv16 vaccines | |
WO2007130327A3 (en) | Influenza virus-like particle (vlp) compositions | |
EP2536428A4 (en) | UNIVERSAL INFLUENZA VACCINES WITH VIRUSIC PARTICLES | |
EP2589604A4 (en) | SHORTEN L1 PROTEIN OF THE TYPE 52 HUMAN PAPILLOMA VIRUS | |
EA201391574A1 (ru) | Фармацевтически приемлемые сокристаллы n-[2-(7-метокси-1-нафтил)этил]ацетамида и способы их получения | |
BR112013030150A2 (pt) | proteína l1 hpv33 truncada ou variante da mesma, ácido nucléico isolado, vetor, célula hospedeira, partícula do tipo viral hpv33, composição, composição farmacêutica ou vacina, método para obter uma proteína l1 hpv33 truncada, método para preparar a partícula do tipo viral hpv33, método para preparar uma vacina, método para prevenir a infecção hpv ou uma doença causada pela infecção de hpv e uso da proteína l1 hpv33 truncada ou variante da mesma | |
BR112014007474A2 (pt) | aumento de rendimento de partícula tipo vírus em plantas | |
PH12020552252A1 (en) | Influenza virus hemagglutinin mutants | |
CR20200507A (es) | Composiciones aav, métodos de fabricación y métodos de uso | |
AR101468A1 (es) | Vacuna en vector recombinante de adenovirus aviar serotipo 9 | |
AR101840A1 (es) | Antígenos del virus del papiloma humano superiores con propiedades inmunológicas superiores, y vacuna que los contiene | |
SG153837A1 (en) | Vaccine against hpv16 and hpv18 and at least another hpv type selected from hpv 31, 45 or 52 | |
MX2019007924A (es) | Vacunas contra la influenza. | |
WO2012036437A3 (ko) | 면역성 펩타이드 및 그 펩타이드를 포함하는 hpv 관련 질환 예방 또는 치료용 조성물 | |
WO2010111586A3 (en) | Mucosal immunization | |
AU2018325899A1 (en) | Method for producing influenza HA split vaccine | |
MX2014000522A (es) | Composicion y metodo para tratar virus del papiloma humano (vph). |